Abbott Laboratories against Thermo Fisher Scientific — live side-by-side technical comparison.
Prices as of 2026-11-09T20:06:58+00:00 UTC · updates daily
TMO leads 6 of the 7 windows we measure — over 1 month ABT is +10.9% and TMO +8.9%; over year to date ABT is -11.8% and TMO +23.6%. The ABT/TMO price ratio stands at 0.1537, below its 50-day average of 0.1572, and below the 200-day average of 0.1858. A ratio above its own average means ABT is gaining on TMO; on this reading the recent edge belongs to TMO.
Compare ABT and TMO: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| ABT | TMO | |
|---|---|---|
| Price | $110.51 | $718.97 |
| 1 day | +0.5% | +3.5%lead |
| 5 days | +0.3% | +4.9%lead |
| 1 month | +10.9%lead | +8.9% |
| 6 months | +31.1% | +54.1%lead |
| Year to date | -11.8% | +23.6%lead |
| 1 year | -12.5% | +25.6%lead |
| 2 years | -5.2% | +30.3%lead |
| 52-week position | 57% of range | 100% of range |
| 52-week range | $81.97–$132.03 | $435.27–$719.05 |
| vs 50-day average | above $103.97 | above $662.75 |
| vs 200-day average | above $101.52 | above $553.44 |
| RSI (14) | 59 | 61 |
| Market cap | $190.4B | $257.4B |
| Analyst target | $118.52 (+7.8%) | $752.12 (+8.3%) |
| Analysts | 26 | 25 |
| Consensus | Buy | Strong buy |
| Next earnings | Jan 28, 2027 | Jan 28, 2027 |
ABT trades at $110.51, above its 50-day average of $103.97, and above the 200-day at $101.52. It sits at 57% of its 52-week range ($81.97–$132.03); 14-day RSI is 59, in neutral territory; an average session moves it about 3.2%. For levels, the first level overhead is $110.61 (0.1% away) and the first support below is $104.55 (5.4% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TMO trades at $718.97, above its 50-day average of $662.75, and above the 200-day at $553.44. It sits at 100% of its 52-week range ($435.27–$719.05); 14-day RSI is 61, in neutral territory; an average session moves it about 3.4%. For levels, the first level overhead is $718.97 (0.0% away) and the first support below is $700.00 (2.6% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
Both move about the same amount day to day (3.2% and 3.4% of price), so the same position size carries comparable risk in either.
The comparison turns on those levels: ABT clearing $110.61 or losing $104.55; TMO clearing $718.97 or losing $700.00. Until one of them gives way, the relative reading above stands.